<div>Discussing a would-be ARVO 2020 presentation examining the use of anterior chamber intracameral dexamethasone drug-delivery suspen for postoperative inflammation in patients undergoing vitreoretinal surgery.</div>

Discussing a would-be ARVO 2020 presentation examining the use of anterior chamber intracameral dexamethasone drug-delivery suspen for postoperative inflammation in patients undergoing vitreoretinal surgery.

Daniel Kiernan, MD: Dexycu for Inflammation Post-Vitreoretinal Surgery

<div>Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.<br>
<br>
<br>
<br>

</div>

News

Science

Medicine

Health & Fitness

Business News

Life Sciences

Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.

Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.<br>
<br>
<br>
<br>



Share Daniel Kiernan, MD: Dexycu for Inflammation Post-Vitreoretinal Surgery

Sign up to save your podcasts

Daniel Kiernan, MD: Dexycu for Inflammation Post-Vitreoretinal Surgery

Daniel Kiernan, MD: Dexycu for Inflammation Post-Vitreoretinal Surgery

More shows like HCPLive Podcasts

Evidence-Based GI: An ACG Publication and Podcast